How to deal with advanced cases of neuroblastoma detected by mass screening: A report from the pediatric oncology study group of the Kyushu area of Japan

This publication has 11 references indexed in Scilit:

• S-100 Positive Undifferentiated Neuroblastomas with a Special Reference to the Tumor Stroma Related to Favorable Prognosis
  Pathology - Research and Practice, 1992
• Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children
  The Journal of Pediatrics, 1991
• Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study.
  Journal of Clinical Oncology, 1990
• Improved survival rates in children over 1 year of age with stage III or IV neuroblastoma following an intensive chemotherapeutic regimen
  Journal of Pediatric Surgery, 1989
• Flow cytometric DNA analysis of Neuroblastoma and Ganglioneuroma. A 10-year retrospective study
  Cancer, 1988
• Association of Multiple Copies of the N-mycOncogene with Rapid Progression of Neuroblastomas
  New England Journal of Medicine, 1985
• Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of Neuroblastomas
  JNCI Journal of the National Cancer Institute, 1984
• Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable Neuroblastoma
  New England Journal of Medicine, 1984
• Neuroblastoma. Mass screening for early detection and its prognosis
  Cancer, 1984
• A proposed staging for children with neuroblastoma.Children's cancer study group A
  Cancer, 1971